The latest price target for Humanigen Inc (OTC:HGEN) was reported by Credit Suisse on April 3, 2023. The analyst firm set a price target for $0.50 expecting HGEN to rise to within 12 months (a possible 4445.45% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Humanigen Inc (OTC:HGEN) was provided by Credit Suisse, and Humanigen Inc reiterated their underperform rating.

There is no last upgrade for Humanigen Inc

The last downgrade for Humanigen Inc happened on July 13, 2022 when Roth Capital changed their price target from $13 to $2 for Humanigen Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humanigen Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humanigen Inc was filed on April 3, 2023 so you should expect the next rating to be made available sometime around April 3, 2024.

While ratings are subjective and will change, the latest Humanigen Inc (HGEN) rating was a reiterated with a price target of $0.00 to $0.50. The current price Humanigen Inc (HGEN) is trading at is $0.01, which is within the analyst’s predicted range.